Search - tctmd.com

Displaying 461 - 480 of 514

Sort: Relevancy | Date

News Daily News

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

L.A. McKeown

June 01, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Caitlin E. Cox

May 18, 2012

Presentation GI2 2012

What is in the Pipeline for Coronary Artery Disease?

Presenter: Martin B. Leon

April 13, 2012

News Daily News

Un Registro de Nueva York Revela Mejores Resultados con la PCI que con el Tratamiento Médico en Pacientes Estables

Jason Kahn

April 03, 2012

News Daily News

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

Jason Kahn

April 03, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Jason Kahn

March 24, 2012

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

News Industry News

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

February 29, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

Presentation TCT 2012

Gender-specific outcomes after paclitaxel-eluting stent implantation in Japanese patients with coronary artery disease: a sub-analysis of Japan TAXUS Express2 post-marketing...

Presenter: Hiroyuki Okura, Jun-ichi Kotani, Ken Kozuma, Masato Nakamura

January 03, 2012

Presentation TCT 2012

First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial

Presenter: Mengyue Yu, Bo Xu, Yongjian Wu, Hongbing Yan, Jue Chen, Jie Qian, Chaowei Mu, Fenghuan Hu, Weixian Yang, Shubin Qiao, Yuejin Yang, Run-Lin Gao

January 03, 2012

Presentation TCT 2012

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

Presenter: Bo Xu, Jie Qian, Alexandra J. Lansky, Yuejin Yang, Shubin Qiao, Yongjian Wu, Jue Chen, Fenghuan Hu, Weixian Yang, Gary S. Mintz, Martin B. Leon, Run-Lin Gao

January 03, 2012

Presentation TCT 2012

Eight Years Clinical Outcomes After Unrestricted Sirolimus-eluting Stent Implantation for Severe Coronary Artery Disease

Presenter: Alfonso Ielasi, Azeem Latib, Marco Mussardo, Massimo Ferraro, Maria Angela Gullace, Cosmo Godino, Mauro Carlino, Matteo Montorfano, Alaide Chieffo, Antonio Colombo

January 03, 2012

News Daily News

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

Yael L. Maxwell

December 14, 2011

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

Advertisement

CREDO-Kyoto Published: Extended DAPT Appears to Raise Bleeding Without Curbing Ischemic Events

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

What is in the Pipeline for Coronary Artery Disease?

Un Registro de Nueva York Revela Mejores Resultados con la PCI que con el Tratamiento Médico en Pacientes Estables

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Gender-specific outcomes after paclitaxel-eluting stent implantation in Japanese patients with coronary artery disease: a sub-analysis of Japan TAXUS Express2 post-marketing...

First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

Eight Years Clinical Outcomes After Unrestricted Sirolimus-eluting Stent Implantation for Severe Coronary Artery Disease

Clopidogrel Prescriptions Not Being Filled Fast Enough, If at All

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content